Status:
COMPLETED
Fast-Release Orodispersible Tramadol Tablet (Tradonal Odis®) as Analgesia for Hysterosalpingography
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Infertility
Pain
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
This study evaluates the analgetic effects of the fast-release orodispersible tramadol tablet. Tramadol acts through a weak affinity for μ receptors and secondly by inhibiting noradrenaline and serot...
Detailed Description
Four arm prospective randomized double blinded trial Patients that need a HSG as part of their diagnostic work-up and are eligible for randomization are counseled about possible participation. After ...
Eligibility Criteria
Inclusion
- \> 18 and \< 45 years
- Written informed consent
Exclusion
- Contra-indication to tramadol, morphine or to other opioids
- Concomitant use of MAO inhibitors or use less than 2 weeks prior to procedure
- Use of any other CNS-acting drug
- Contra-indication to radio-contrast medium (allergy)
- Patient already taking analgetics
- History of cervical stenosis
- Presence of pelvic inflammatory disease or any other condition causing pelvic pain
- Clinical and/or laboratory evidence of any major disease
- Pregnant or lactating
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2009
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT00893412
Start Date
November 1 2008
End Date
April 1 2009
Last Update
May 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Brussel
Brussels, Belgium, 1090